Association of P3 amplitude to treatment completion in substance dependent individuals

Psychiatry Research

Volumn 177, Issue 1-2, 2010, Pages 223-227

  Wan, Li ^a,b   Baldridge, Robyn M ^a   Colby, Amanda M ^a   Stanford, Matthew S ^a  

^a BAYLOR UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Impulsivity; P3 amplitude; Substance dependence; Treatment completion

Indexed keywords

ALCOHOL;

ADULT; AGGRESSION; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EVENT RELATED POTENTIAL; EVOKED RESPONSE; FEMALE; HUMAN; IMPULSIVENESS; MALE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; RELIABILITY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUBSTANCE ABUSE;

ADULT; DISCRIMINANT ANALYSIS; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PATTERN RECOGNITION, VISUAL; PHOTIC STIMULATION; PREDICTIVE VALUE OF TESTS; REACTION TIME; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 77952091280     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.01.033     Document Type: Article

References (56)

1. Alterman A.I., McKay J.R., Mulvaney F.D., McLellan A.T. Prediction of attrition from day hospital treatment in lower socioeconomic cocaine-dependent men. Drug and Alcohol Dependence 1996, 40:227-233.
2. Alterman A.I., Kampman K., Boardman C.R., Cacciola J.S., Rutherford M.J., McKay J.R., Maany I. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug and Alcohol Dependence 1997, 46:79-85.
3. Babor T.F., de la Fuente J.R., Saunders J., Grant M. AUDIT, The Alcohol Use Disorders Identification Test. Guidelines for Use in Primary Health Care 1992, World Health Organization, Switzerland.
4. Bauer L.O. Electroencephalographic and autonomic predictors of relapse in alcohol-dependent patients. Alcoholism: Clinical and Experimental Research 1994, 18:755-760.
5. Bauer L.O. Frontal P3 decrements, childhood conduct disorder, family history, and the prediction of relapse among abstinent cocaine abusers. Drug and Alcohol Dependence 1997, 44:1-10.
6. Bauer L.O. CNS recovery from cocaine, cocaine and alcohol, or opioid dependence, a P300 study. Clinical Neurophysiology 2001, 112:1508-1515.
7. Begleiter H., Porjesz B., Bihari B., Kissin B. Event-related brain potentials in boys at risk for alcoholism. Science 1984, 225:1493-1496.
8. Berman S.M., Whipple S.C., Fitch R.J., Noble E.P. P3 in young boys as a predictor of adolescent substance use. Alcohol 1993, 10:69-76.
9. Branchey M.H., Buydens-Branchey L., Lieber C.S. P3 in alcoholics with disordered regulation of aggression. Psychiatry Research 1988, 25:49-58.
10. Carroll K.M., Power M.E., Bryant K., Rounsaville B.J. One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. The Journal of Nervous and Mental Disease 1993, 181:71-79.
11. Carroll K.M., Rounsaville B.J., Bryant K.J. Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. Journal of Studies on Alcohol 1993, 54:199-208.
12. Casco C., Forcella M., Beretta G., Grieco A., Campana G. Long-term effects of MDMA Ecstasy on the human central nervous system revealed by visual evoked potentials. Addiction Biology 2005, 10:187-195.
13. Ciraulo D., Piechniczek-Buczek J., Iscan E. Outcome predictors in substance use disorders. The Psychiatric Clinics of North America 2003, 26:381-409.
14. Dimoska A., Johnstone S.J. Neural mechanisms underlying trait impulsivity in non-clinical adults: stop-signal performance and event-related potentials. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007, 31:443-454.
15. Donchin E., Coles M.G.H. Is the P300 component a manifestation of context updating?. Behavioral and Brain Sciences 1988, 11:355-372.
16. Ehrman R.N., Robbins S.J., Cornish J.W. Results of a baseline urine test predict levels of cocaine use during treatment. Drug and Alcohol Dependence 2001, 62:1-7.
17. First M., Spitzer R., Gibbon M., Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version SCID-CV 1996, American Psychiatric Press, Washington DC.
18. First M., Gibbon M., Williams J., Spitzer R. SCID Screen Patient Questionnaire Extended SCID-PQ for Windows 1999, Multi-Health Systems, Toronto, Canada.
19. Fjell A.M., Walhovd K.B. Life-span changes in P3a. Psychophysiology 2004, 41:575-583.
20. Gamma A., Brandeis D., Brandeis R., Vollenweider F.X. The P3 in 'ecstasy' polydrug users during response inhibition and execution. Journal of Psychopharmacology 2005, 19:504-512.
21. Goddard H.H. Human Efficiency and Levels of Intelligence 1920, Princeton University Press, Princeton, NJ.
22. Hill S.Y. Trajectories of alcohol use and electrophysiological and morphological indices of brain development: distinguishing causes from consequences. Annals of the New York Academy of Sciences. 2004, 1021:245-259.
23. Hill S.Y., Steinhauer S., Lowers L., Locke J. Eight-year longitudinal follow-up of P3 and clinical outcome in children from high-risk for alcoholism families. Biological Psychiatry 1995, 37:823-827.
24. Iacono W.G., Carlson S.R., Malone S.M., McGue M. P3 event-related potential amplitude and the risk for disinhibitory disorders in adolescent boys. Archives of General Psychiatry 2002, 59:750-757.
25. Kampman K.M., Alterman A.I., Volpicelli J.R., Maany I., Muller E.S., Luce D.D., Mulholland E.M., Jawad A.F., Parikh G.A., Mulvaney F.D., Weinrieb R.M., O, Brien C.P. Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychology of Addictive Behaviors 2001, 15:52-59.
26. Kedzior K., Badcock J., Martin-Iverson M. Validity and consistency of self-reports regarding substance use in general research volunteers, including regular cannabis users and schizophrenia patients. Substance Use & Misuse 2006, 41:743-750.
27. Kelly J.F., Moos R. Dropout from 12-step self-help groups, prevalence, predictors, and counteracting treatment influences. Journal of Substance Abuse Treatment 2003, 24:241-250.
28. Kouri E.M., Lukas S.E., Mendelson J.H. P300 assessment of opiate and cocaine users, effects of detoxification and buprenorphine treatment. Biological Psychiatry 1996, 40:617-628.
29. Kok A., Ramautar J.R., De Ruiter M.B., Band G.P.H., Ridderinkhof K.R. ERP components associated with successful and unsuccessful stopping in a stop-signal paradigm. Psychophysiology, 2004, 42:9-20.
30. Kosten T.A., Gawin F.H., Kosten T.R., Rounsaville B.J. Gender differences in cocaine use and treatment response. Journal of Substance Abuse Treatment 1993, 10:63-66.
31. McKay J.R., Alterman A.I., Rutherford M.J., Cacciola J.S., McLellan A.T. The relationship of alcohol use to cocaine relapse in cocaine dependent patients in an aftercare study. Journal of Studies on Alcohol 1999, 60:176-180.
32. Moeller F.G., Dougherty D.M., Barratt E.S., Schmitz J.M., Swann A.C., Grabowski J. The impact of impulsivity on cocaine use and retention in treatment. Journal of Substance Abuse Treatment 2001, 21:193-198.
33. Moeller F.G., Barratt E.S., Fischer C.J., Dougherty D.M., Reilly E.L., Mathias C.W., Swann A.C. P300 event-related potential amplitude and impulsivity in cocaine-dependent subjects. Neuropsychobiology 2004, 50:167-173.
34. Marques-Teixeira J.E., Barbosa M.F. Emotional states and informational brain processing in drug addicts free of drugs, an ERPs study. International Journal of Clinical Practice 2005, 9:213-220.
35. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1992, 9:199-213.
36. Mulvaney F.D., Alterman A.I., Boardman C.R., Kampman K. Cocaine abstinence symptomatology and treatment attrition. Journal of Substance Abuse Treatment 1999, 16:129-135.
37. Muntaner C., Walter D., Nagoshi C., Fishbein D., Haertzen C.A., Jaffe J.H. Self-report vs. laboratory measures of aggression as predictors of substance abuse. Drug and Alcohol Dependence 1990, 61:1-11.
38. Orwin R., Garrison-Mogren R., Jacobs M.L., Sonnefeld L.J. Retention of homeless clients in substance abuse treatment, findings from the NIAAA cooperative agreement program. Journal of Substance Abuse Treatment 1999, 17:45-66.
39. Overtoom C.C.E., Kenemans J.L., Verbaten M.N., Kemmer C., van der Molen M.W., van Engeland H.M., Buitelaar J.K., Koelega H.S. Inhibition in children with attention-deficit/hyperactivity disorder: a psychophysiological study of the stop task. Biological Psychiatry 2002, 51:668-676.
40. Patton J.H., Stanford M., Barratt E.S. Factor structure of the Barratt Impulsiveness Scale. Journal of Clinical Psychology 1995, 51:768-774.
41. Patkar A.A., Thornton C.C., Berrettini W.H., Gottheil E., Weinstein S.P., Hill K.P. Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures. Journal of Substance Abuse Treatment 2002, 22:134-145.
42. Patkar A.A., Murray H.W., Mannelli P., Gottheil E., Weinstein S.P., Vergare M.J. Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African-American cocaine-dependent patients. Journal of Addictive Diseases 2004, 23:109-122.
43. Porjesz B., Begleiter H. Human brain electrophysiology and alcoholism. Alcohol and the Brain 1985, 139-182. Plenum, New York. D.V. Tarter, D.V. Thiel (Eds.).
44. Poling J., Kosten T.R., Sofuoglu M. Treatment outcome predictors for cocaine dependence. The American Journal of Drug and Alcohol Abuse 2007, 33:191-206.
45. Polich J., Pollock V.E., Bloom F.E. Meta-analysis of P300 amplitude from males at risk for alcoholism. Psychological Bulletin 1994, 115:55-73.
46. Prichep L.S., Alper K.R., Kowalik S.C., Vaysblat L.S., Merkin H.A., Tom M., John E.R., Rosenthal M.S. Prediction of treatment outcome in cocaine dependent males using quantitative EEG. Drug and Alcohol Dependence, 1999, 54:35-43.
47. Ramautar J., Kok A., Ridderinkhof K.R. Effects of stop-signal modality on the N2/P3 complex elicited in the stop-signal paradigm. Biological Psychology 2006, 72:96-109.
48. Reiber C., Ramirez A., Parent D., Rawson R.A. Predicting treatment success at multiple timepoints in diverse patient populations of cocaine-dependent individuals. Drug and Alcohol Dependence 2002, 68:35-48.
49. Schmitz J.M., Bordnick P.S., Kearney M.L., Fuller S.M., Breckenridge J.K. Treatment outcome of cocaine-alcohol dependent patients. Drug and Alcohol Dependence 1997, 47:55-61.
50. Skinner H.A. The drug abuse screening test. Addictive Behaviors 1982, 7:363-371.
51. Substance Abuse and Mental Health Services Administration Results from the 2005 National Survey on Drug Use and Health, National Findings 2006, DHHS Publication, Rockville, MD.
52. Trent J. Inventing the Feeble Mind: A History of Mental Retardation in the United States 1994, University of California Press, Berkeley, CA.
53. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI) 1999, Harcourt Assessment, San Antonio, TX.
54. Weiss R.D., Martinez-Raga J., Griffin M.L., Greenfield S.F., Hufford C. Gender differences in cocaine dependent patients: a 6 month follow-up study. Drug and Alcohol Dependence 1997, 44:35-40.
55. Winterer G., Klöppel B., Heinz A., Schmidt L.G., Frick K., Herrmann W.M. Quantitative EEG (QEEG) analysed with artificial neural networks predicts relapse in patients with chronic alcoholism and points to a frontally pronounced disturbance. Psychiatry Research 1998, 78:101-113.
56. Wong C.J., Badger G.J., Sigmon S.C., Higgins S.T. Examining possible gender differences among cocaine-dependent outpatients. Experimental and Clinical Psychopharmacology 2002, 10:316-323.